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Abstract 
Accumulating evidence has indicated that the inflammatory response is important for tumor 
promotion. However, the mechanisms underlying the induction of the inflammatory response 
in cancer tissues and how it promotes tumorigenesis remain poorly understood. We 
constructed several mouse models that develop inflammation-associated gastric and 
intestinal tumors and examined the in vivo mechanisms of tumorigenesis. Of note, the 
activation of cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) pathway and Toll-like 
receptor (TLR)/MyD88 signaling cooperatively induced the generation of an inflammatory 
microenvironment, which is required for early-stage tumorigenesis. The inflammatory 
response in the stroma induces TNF-α signaling in tumor cells, and the NOX1/ROS signaling 
pathway is activated downstream. In addition, the inflammatory pathway induces the 
expression of TLR2 in tumor epithelial cells. Both the NOX1/ROS and TLR2 pathways in 
tumor cells contribute to the acquisition and maintenance of stemness, which is an important 
tumor-promoting mechanism stimulated by inflammation. We also found that inflammation 
promotes malignant processes, like submucosal invasion, of TGF-β signaling-suppressed 
tumor cells through the activation of MMP2 protease. We also showed that mutant p53 
induces innate immune and inflammatory signaling in the tumor stroma by a gain-of-function 
mechanism of mutant p53, which may explain the “cancer-induced inflammation” 
mechanism. These results indicate that the regulation of the inflammatory microenvironment 
via the inhibition of the COX-2/PGE2 and TLR/MyD88 pathways in combination may be an 
effective preventive or therapeutic strategy against gastrointestinal cancer development and 
malignant progression, especially those carrying p53 gain-of-function mutations. 
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Introduction 
It has been established that inflammatory responses play a tumor-promoting role in 
gastrointestinal cancer development. Epidemiological studies have shown that the regular 
use of non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin, reduces the risk of 
gastrointestinal cancer (Thun et al., 1991; Thun et al., 2012). NSAIDs suppress the 
enzymatic activity of cyclooxygenase (COX)-1 and COX-2, rate-limiting enzymes for 
prostaglandin (PG) biosynthesis. We previously showed using genetic mouse models that 
COX-2 and its downstream product PGE2 play an essential role in tumor development in the 
intestine and stomach (Oshima et al., 1996; Sonoshita et al., 2001; Oshima et al., 2004). In 
the inflammatory microenvironment generated in tumor stroma, the infiltration of tumor-
associated macrophages (TAMs), which express cytokines, chemokines, growth factors and 
proteases, can be seen (Pollard, 2009). TAMs support not only tumor cell migration and 
proliferation but also metastasis through chemokine CCL2 signaling (Kitamura et al., 2015). It 
has also been shown that the transcription factors NF-κB and Stat3 are activated in both 
inflamed tissues and tumors (He and Karin, 2011), and these transcription factors as well as 
the COX-2/PGE2 pathway link inflammation and cancer. 
To examine the mechanism of inflammation in gastrointestinal tumorigenesis in 
greater detail, we have constructed genetically engineered mouse models that develop 
tumors in the stomach (Gan mice) or intestine (Apc∆716 mice) and examined how the 
inflammatory microenvironment is generated in tumor tissues and how such a 
microenvironment promotes tumor development and malignant progression. In this chapter, 
we will summarize what we have learned from these mouse models. 
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1. COX-2/PGE2 inflammatory pathway in intestinal tumorigenesis 
ApcD716 mice that carry a truncation mutation in the Apc gene develop intestinal tumors 
caused by canonical Wnt signaling activation in epithelial cells (Oshima et al., 1995). In the 
intestinal tumors of ApcD716 mice, the COX-2 expression is induced in stromal fibroblasts but 
not in tumor cells, which triggers the generation of an inflammatory microenvironment via the 
biosynthesis of PGE2 (Sonoshita et al., 2002). Importantly, the deletion of the COX-2 gene or 
pharmacological inhibition of COX-2 in ApcD716 mice resulted in a significant decrease in 
polyp numbers, indicating that a COX-2-dependent inflammatory microenvironment is critical 
for tumor development (Oshima et al., 1996; Oshima et al., 2001). The tumor-promoting 
mechanism of PGE2 remains poorly understood, but it has been reported that PGE2 induces 
the cancer stem cell expansion by activating NF-kB, via signaling through its receptor EP4 
(Wang et al., 2015). Based on these results, COX-2 selective inhibitors were expected to be 
an effective chemopreventive agent for colon cancer, and indeed, the treatment of familial 
adenomatous polyposis patients with celecoxib, a COX-2 inhibitor, suppressed the 
development of intestinal polyposis (Steinbach et al., 2000). However, COX-2 inhibitors have 
not been widely used for cancer prevention because of potential serious side effects on the 
circulation system in certain populations. Thus, other target molecules, like the PGE2 
receptor, are now thought to be potential appropriate targets for colon cancer prevention. 
 
2. COX-2/PGE2 inflammatory pathway in gastric tumorigenesis 
We first constructed a gastritis mouse model, K19-C2mE mice, via the transgenic 
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expression of COX-2 and mPGES-1, an inducible PGE converting enzyme, in gastric 
mucosa. K19-C2mE mice develop inflammation-associated mucosal hyperplasia in the 
stomach caused by increased levels of PGE2 (Oshima et al., 2004). Notably, the additional 
activation of canonical Wnt signaling in K19-C2mE stomach epithelial cells by the 
transgenic induction of Wnt1 caused the development of glandular-type tumors (Oshima et 
al., 2006; oshima et al., 2009). These genetic results indicate that the cooperation of 
oncogenic Wnt activation and a COX-2-induced inflammatory response induces gastric 
tumorigenesis. We named this gastric tumor model “Gan (gastric neoplasia) mice”. Later, 
the Cancer Genome Atlas (TCGA) network reported the results of a genome research 
analysis of human gastric cancers (The Cancer Genome Atlas Research Network, 2014). 
Using the TCGA database for gastric cancer, we examined the activated signaling 
pathways and found that the Wnt signaling, COX-2, and NF-κB inflammatory pathways are 
activated simultaneously in intestinal-type gastric cancers (Echizen et al., 2016). 
Accordingly, Gan mice recapitulate intestinal-type human gastric cancer development, from 
the molecular mechanisms to the histological phenotypes. 
We next examined the expression profiles of the gastritis and gastric tumors that 
developed in K19-C2mE mice and Gan mice, respectively. On a microarray analysis, we 
found that a tumor-suppressor microRNA, miR-7a, was significantly downregulated by 
inflammatory responses (Kong et al., 2012). MiR-7a suppresses the expression of EGFR, 
thus its downregulation may support tumor cell proliferation via the activation of EGFR 
signaling (Kefas et al., 2008). By further RNA sequencing of gastritis and tumor tissues, we 
found that the expression profiles of gastric tumors were similar to those of gastritis 
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(Echizen et al., 2016) (Fig. 1A). Of note, stem cell-related genes, such as Cd44, Sox2, 
Noxo1, Sox9, and Prom1 were upregulated in both gastritis and gastric tumors, while the 
expression of differentiation-related genes was downregulated, suggesting that these 
changes in the expression of tumors were induced by an inflammation-dependent 
mechanism (Echizen et al., 2016) (Fig. 1B). Accordingly, the COX-2/PGE2-induced 
inflammatory microenvironment may promote tumorigenesis by maintaining the tumor cells 
in an undifferentiated state. 
 
3. TNF-α signaling in gastric tumorigenesis 
Although TNF-α was isolated as a “tumor necrosis” factor, mouse genetic studies have 
indicated that TNF-α plays a tumor-promoting role in several solid tumors (Balkwill, 2009). 
In addition, a polymorphism of the TNF-α gene was linked to the gastric cancer incidence 
(El-Omar et al., 2002). In the Gan mouse gastric tumors, inflammatory cytokine levels were 
elevated because of constitutive activation of COX-2/PGE2 pathway. To examine the role of 
TNF-α in gastric tumorigenesis, the TNF-α gene was deleted in Gan mice by crossing with 
Tnf-/- mice, which resulted in significant suppression of gastric tumorigenesis (Oshima et 
al., 2014). Notably, the transplantation of TNF-α-wild-type bone marrow to Tnf-/- Gan mice 
caused gastric tumor development, indicating that the TNF-α expression in the infiltrated 
cells in tumor stroma is important for tumorigenesis. 
A microarray analysis using TNF-α wild-type and knockout Gan mouse tumors 
revealed that stem cell-related genes, such as Cd44, Noxo1, Prom1, and EphB3, were 
upregulated in tumor tissues in a TNF-α-dependent mechanism (Fig. 2). These genes 
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overlap with the upregulated genes in K19-C2mE gastritis. We therefore performed 
functional screening for TNF-α-dependent genes using gastric cancer cell lines and found 
that the inhibition of Noxo1 expression significantly suppressed soft-agar colony formation 
of all examined cell lines.  
Noxo1 is a component of the NADPH oxidase 1 (NOX1) complex, which produces 
reactive oxygen species (ROS). It has been shown that NOX1 complex is important for 
tumorigenesis through the suppression of protein tyrosine phosphatases, which results in 
activation of oncogenic pathway (Block and Gorin, 2012). Furthermore, the expression of 
Rac1, another component of the NOX1 complex, is induced in ApcMin mouse intestinal 
tumor cells, and NOX1-induced ROS production is responsible for the maintenance of the 
stemness of tumor cells (Myant et al., 2013). We also found that Noxo1 gene knockdown in 
gastric cancer cells resulted in the suppression of sphere formation, suggesting the 
suppression of the stemness (Block and Gorin, 2012). Consistently, a low level of ROS 
signaling is important for maintaining stem cells’ inherent properties (Gorrini et al, 2013). It 
is therefore possible that NOX1/ROS signaling is an important mechanism that links TNF-α-
associated inflammation and tumor cell stemness (Fig. 2). 
 
4. The TLR/MyD88 innate immune pathway in gastric tumorigenesis 
When Gan mice were raised in germ-free conditions, both gastritis and gastric 
tumorigenesis were suppressed significantly, although the COX-2/PGE2 pathway was 
constitutively activated (Oshima et al., 2011). Furthermore, infection of Helicobacter felis, a 
close relative to H. pylori, to germ-free Gan mouse stomach induced gastric tumor 
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development. These results suggest that innate immune signaling for commensal bacteria 
is required for COX-2/PGE2-induced inflammation in the stomach. To assess this possibility, 
we disrupted gene encoding MyD88, an effector molecule for Toll-like receptors (TLRs) in 
Gan mice by crossing with Myd88-/- mice (Maeda et al., 2016). As expected, the 
inflammatory responses were completely suppressed by the shutdown of TLR/MyD88 
signaling, while COX-2 and mPGES-1 were constitutively expressed in the gastric mucosa. 
Moreover, gastric tumorigenesis in Gan mice was also suppressed when Myd88 was 
deleted in bone marrow cells. These results indicate that TLR/MyD88 signaling and the 
COX-2/PGE2 pathway in the inflammatory cells cooperatively induce the generation of an 
inflammatory microenvironment in tumor tissues through the induction of cytokines and 
chemokines (Fig. 3). 
Interestingly, the TLR2 expression is highly increased in tumor epithelial cells, and its 
level was decreased significantly when the TLR/MyD88 pathway was suppressed, 
indicating that stromal TLR/MyD88 signaling induces the epithelial TLR2 pathway (Fig. 3). 
Interestingly, it has been shown that signaling through TLR2 and its coreceptor CD14 
through MyD88 in the intestinal and mammary “epithelial cells” is essential for the 
maintenance of normal stem cell properties (Scheeren et al., 2014). Furthermore, the 
disruption of Myd88 in ApcMin mouse intestinal epithelia caused a significant decrease in the 
numbers of intestinal polyps. These results are consistent with the original finding that 
epithelial cell intrinsic signaling of TLR2/4 receptors is required for homeostasis and the 
regeneration of intestinal mucosa (Rakoff-Nahoum and Medzhitov, 2007). It is therefore 
possible that the TLR2 pathway in the epithelia induced by inflammatory cytokines from the 
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stroma plays a role in the acquisition of stem cell properties by tumor cells. Indeed, it has 
been shown that the suppression of TLR2 signaling in a gp130F/F gastric tumor mouse 
model resulted in the significant suppression of tumor development (Tye et al., 2012). In the 
gp130F/F model, constitutive activation of gp130 induced Stat3 activation-dependent 
inflammation and gastric tumorigenesis, and TLR2 gene deletion suppressed tumorigenesis 
without suppression of inflammation. Accordingly, innate immune pathways through 
TLR/MyD88 are important in stromal cells, possibly in macrophages, and tumor epithelial 
cells, and their interplay is important for tumor promotion (Fig. 3). Although ligands for these 
TLRs have not been identified, tumor cell-derived molecules may function as danger signal 
ligands for TLRs. 
These results suggest that the simultaneous inhibition of COX-2/PGE2 and 
TLR/MyD88 pathways in combination will be an effective preventive strategy against gastric 
cancer development. 
 
5. Inflammatory pathway for malignant progression (TGF-b signaling suppression) 
As described above, it has been established that the COX-2/PGE2, NF-κB and Stat3 
pathways play a role in the early stage of intestinal tumorigenesis. To explore this concept, 
most studies were performed using Apc mutant mice or azoxymethane (AOM)/dextran 
sodium sulfate (DSS)-treated mice that develop benign adenomas. Although chronic 
inflammation is associated also with malignant colon cancer, whether or not an 
inflammatory microenvironment promotes malignant progression, including submucosal 
invasion and metastasis, has been unclear.  
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TGF-β signaling induces the differentiation of undifferentiated gastrointestinal 
epithelial cells; therefore, the suppression of TGF-β signaling promotes the malignant 
progression of gastrointestinal cancers. Consistently, genes encoding TGF-β type-II 
receptor (TGFBR2) and Smad4 are frequently mutated in human colon cancer, suggesting 
that these genes are tumor suppressors (The Cancer Genome Atlas Network, 2012). 
Moreover, it has also been shown that glycogen synthase-3 (GSK3) induces invasion and 
EMT through negative regulation of TGF-b signaling (Cervello et al, 2017). We previously 
showed that the disruption of Tgfbr2 or Smad4 in ApcD716 mice resulted in the induction of 
submucosal invasion of intestinal tumors, confirming the tumor-suppressor role of the TGF-
β pathway (Kitamura et al., 2007; Oshima et al., 2015). An intensive histological analysis of 
ApcD716 Tgfbr2-/- compound mice showed that only large tumors (>1 mm in diameter) had 
an invasive phenotype, with smaller ones in the same mice never demonstrating invasion. 
Over this size point (1 mm in diameter), COX-2 expression is induced in the stromal 
fibroblasts, and the production of inflammatory cytokines and growth factors is induced 
(Seno et al., 2002). These results suggest that an inflammatory microenvironment 
significantly contributes to the induction of submucosal invasion in intestinal tumors of TGF-
β signaling-suppressed epithelial cells.  
To assess this hypothesis, we treated Tgfbr2 knockout mice with DSS, which induces 
ulcerative colitis in the colon (Oshima et al., 2015). Disruption of the Tgfbr2 gene in non-
inflamed intestinal mucosa did not cause any morphological changes, indicating that TGF-β 
signaling is not required for intestinal homeostasis. However, in the colonic mucosa of DSS-
treated Tgfbr2-/- mice, regenerating epithelial cells from ulcers showed submucosal 
 11 
invasion. Invaded epithelial cells continued to proliferate for over 10 months, resulting in the 
development of colonic invasive adenocarcinoma with collagen fiber deposition in the 
stroma. In the stroma of invasive tumors, macrophages infiltrate and express MT1-MMP, 
which further activates MMP2. MMP2 is an important protease for the promotion of tumor 
invasion because it degrades basement membrane components, such as type IV collagen 
and laminin. 
Of note, Tgfbr2 gene deletion in the regenerating mucosa resulted in expansion of 
CD44-positive undifferentiated epithelial cells in organoids, forming a long crypt structure, 
which indicates that TGF-β signaling is required for the differentiation of regenerating 
intestinal epithelial cells. Accordingly, in the colonic mucosa of ulcerative colitis patients, the 
suppression of TGF-β signaling may be sufficient to cause invasive colon cancer, as the 
mucosa is continuously inflamed and epithelial cells are regenerated (Fig. 4A). However, in 
sporadic colon cancer tissues, Wnt signaling activation is an initial step for tumorigenesis, 
and an inflammatory microenvironment is constructed via the induction of COX-2 
expression in the stroma when tumors grow over 1 mm in diameter. In such adenoma 
tissues, MMP2 is activated, and the cooperation of inflammation and TGF-β signaling 
suppression in the Wnt-activated adenoma cells causes submucosal invasion (Fig. 4B). 
Accordingly, the regulation of the inflammatory microenvironment may prevent the invasion 
of intestinal tumors. It has been reported that bioactive sphingolipids play critical roles in 
cancer and inflammatory conditions in including ulcerative colitis (Pyne et al., 2016; 
Espaillat et al., 2017). Accordingly, it is possible that sphigolipids also promote CRC 
invasion through induction of inflammatory responses. 
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6. Inflammatory pathway for malignant progression (mutant p53 expression) 
TP53 is another important tumor suppressor in most cancers, and the p53 mutation is found 
in more than 60% of human colon cancers (The Cancer Genome Atlas Network, 2012). 
TP53 has shown to regulate expression of oncogenic as well as tumor suppressor 
microRNAs, thus targeted therapies to stabilize TP53 have been developed as possible 
anti-cancer drugs (McCubrey et al., 2017). Furthermore, a majority of p53 mutations are 
missense type, which results in amino acid substitutions at hot spots, and mouse genetic 
study has indicated that mutant p53 protein promotes tumorigenesis via a “gain-of-function” 
(GOF) mechanism (Olive et al., 2004). It was recently reported that mutant p53 protein 
induces the modification of the chromatin structure via a GOF mechanism, which further 
results in the activation of transcription factors by increasing the promoter accessibility 
(Pfister et al., 2015; Zhu et al., 2015). To examine the GOF of mutant p53 in malignant 
progression of intestinal tumors, we crossed ApcΔ716 and Trp53R270H mice to generate 
compound mice. As expected, the expression of mutant p53 R270H induced the 
submucosal invasion of tumor cells, which was rarely found in p53-deleted ApcΔ716 mice 
(Nakayama et al., 2017). We also confirmed that promoter accessibility was increased by 
the mutant p53 R270H expression in tumor cells, which was associated with the 
upregulation of about 350 genes. A pathway analysis using the expression data revealed 
inflammatory signaling and innate immune pathways, like NF-κB, TLRs, and cytokines. 
Consistently, the levels of cytokines and chemokines secreted in the culture medium were 
increased significantly in intestinal tumor cells that carried p53 mutations. Accordingly, the 
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generation of an inflammatory microenvironment in malignant cancer may be caused by 
mutant p53 GOF at least in part, as a “cancer-elicited inflammation” mechanism. 
 
Conclusion 
Both the COX-2/PGE2 pathway and TLR/MyD88 signaling play key roles in cancer 
development via the generation of an inflammatory microenvironment. It is therefore 
possible that targeting the COX-2/PGE2 pathway together with TLR/MyD88 signaling in 
combination will be an effective prevention strategy against gastrointestinal cancers. In the 
inflammatory environment, TNF-α signaling induces NOX1/ROS signaling, and Stat3 
activation causes TLR2 upregulation in tumor cells. These signaling pathways contribute to 
the acquisition of stemness, which may be important mechanisms for inflammation-induced 
tumor promotion. An inflammatory microenvironment also promotes malignant progression, 
such as submucosal invasion, via the activation of MMP2 protease. We also found that 
mutant p53 induces an innate immune response and inflammation by a GOF mechanism, 
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Figure 1. Expression analyses of K19-C2mE mouse gastritis and Gan mouse gastric 
tumors.  (A) Principal component analysis of Gan mouse tumors (red), K19-C2mE gastritis 
(orange), and wild-type normal stomach (green). Not that expression profiles of gastritis and 
gastric tumors are similar. (B) Average-linkage clustering analysis of genotype-specific 
genes using RNA sequencing results of the wild-type normal stomach (WT), K19-C2mE 
mouse gastritis (C2mE), and Gan mouse gastric tumors (Gan).  Stem cell-related genes 
were upregulated (red), while differentiation markers were downregulated (green) in both 
gastritis and gastric tumors (right). (Reproduced from Echizen et al, Cancer Sci, 2016) 
 
Figure 2. A schematic summary of the TNF-a-associated promotion of gastric 
tumorigenesis.  Macrophages are recruited to tumor stroma and express TNF-a, which 
further activates stromal cells including macrophages and fibroblasts as well as tumor cells. 
In tumor epithelial cells, Noxo1 is induced by TNF-a signaling, and NOX1 complex is 
activated, which further leads to increased ROS production. NOX1/ROS pathway may 
promote tumorigenesis through acquisition of stem cell properties. (Reproduced from 
Oshima et al, Oncogene, 2014) 
 
Figure 3. Schematic drawing of interaction of inflammatory cells and cancer cells. In 
macrophages, both TLR/MyD88 and COX-2/PGE2 pathways are required for induction of 
inflammatory cytokines and generation of inflammatory microenvironment. In tumor cells, 
TNF-a signaling induces activation of NOX1/ROS signaling, and gp130 activation induces 
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TLR2 pathway. Both of ROS signaling and TLR2 pathway contribute to acquisition of stem 
cell property, which promotes tumorigenesis. (Reproduced from Echizen et al, Cancer Sci, 
2016) 
 
Figure 4. A schematic drawing of the development of invasive colon cancers in 
regenerating and inflamed mucosa of ulcerative colitis patients (A) and in Wnt signaling-
activated adenomas (B). Inflammatory microenvironment-induced MMP2 activation and 
TGF-b signaling suppression cooperatively induces invasive cancer in the colon. 
(Reproduced from Oshima et al, Cancer Research, 2015) 




